Omnicell vs Cleo
Detailed side-by-side comparison to help you choose the right tool
Omnicell
Healthcare
Healthcare technology platform providing AI-powered analytics, automation, and intelligence for medication and supply management across hospital systems.
Was this helpful?
Starting Price
CustomCleo
Healthcare
AI-powered clinical decision support platform for acute care hospitals, providing real-time patient deterioration detection, sepsis prediction, and workflow optimization to improve outcomes and reduce clinician burnout.
Was this helpful?
Starting Price
CustomFeature Comparison
Scroll horizontally to compare details.
Omnicell - Pros & Cons
Pros
- ✓Market leader with over 7,000 facility installations and deep health system penetration
- ✓End-to-end Autonomous Pharmacy vision covering dispensing, central pharmacy, analytics, and patient engagement
- ✓Strong EHR integration ecosystem supporting all major platforms
- ✓Proven hardware reliability with XT cabinets widely deployed across U.S. hospitals
- ✓Growing cloud analytics capabilities with AI-driven diversion detection and demand forecasting
- ✓Comprehensive 340B compliance tooling integrated into dispensing workflows
- ✓Publicly traded company (NASDAQ: OMCL) with transparent financials and long-term viability
Cons
- ✗No transparent pricing—requires lengthy consultative sales process with custom quoting
- ✗High upfront capital expenditure for hardware installations may be prohibitive for smaller facilities
- ✗Transition to SaaS model means ongoing subscription costs layered on top of hardware investment
- ✗Legacy system migrations can be complex and time-consuming for facilities replacing older Omnicell equipment
- ✗Some users report that the software interface has a steeper learning curve compared to competitors like BD Pyxis
- ✗Limited international presence compared to domestic footprint—non-U.S. facilities may have fewer support options
- ✗Vendor lock-in risk due to proprietary cabinet hardware tied to Omnicell software ecosystem
Cleo - Pros & Cons
Pros
- ✓Aims to consolidate deterioration detection, sepsis prediction, and capacity management into a single acute-care-focused platform, potentially reducing the need to procure and integrate multiple point solutions
- ✓Claims direct integration into existing EHR workflows (Epic, Cerner) so clinicians don't need to learn a separate application
- ✓Configurable alert sensitivity reportedly allows clinical informatics teams to tune the system to their facility's tolerance for alert fatigue
- ✓Describes explainable risk scores showing contributing factors, which if validated would enable clinicians to make informed decisions rather than relying on black-box outputs
- ✓Covers multiple acute care use cases within a single platform, unlike competitors that typically specialize in one domain (imaging, operations, or sepsis scoring alone)
Cons
- ✗Independent verification of the product, its customer base, and clinical outcomes is extremely limited — no peer-reviewed studies, named references, or specific outcome data are publicly available
- ✗Enterprise-only pricing (estimated at $50,000+/year based on comparable platforms) makes it inaccessible for small or rural hospitals without dedicated AI budgets
- ✗As a newer entrant, Cleo lacks the established install base and track record of competitors like Qventus, Viz.ai, or Epic's native tools, increasing procurement risk
- ✗Implementation requires a multi-week integration and calibration period, which may delay time-to-value by 2–3 months
- ✗Limited to acute care settings — organizations looking for outpatient, primary care, or population health AI will need a separate solution
- ✗FDA clearance status is not publicly documented, and no clinical validation studies are available in public databases such as PubMed
Not sure which to pick?
🎯 Take our quiz →🦞
🔔
Price Drop Alerts
Get notified when AI tools lower their prices
Get weekly AI agent tool insights
Comparisons, new tool launches, and expert recommendations delivered to your inbox.